CD8A and neoplasm: Conversely, in vitro administration of CoA or pantethine (a vitamin B5 precursor) can increase CD8+ T cell anti-tumor activity (192, 193); pantethine administration has shown an effect in reducing tumor growth and metabolism in ovarian cancer cells (194).